Track topics on Twitter Track topics that are important to you
After the big disaster with its cat allergy vaccine, Circassia closes a €214M deal to acquire rights from two AstraZeneca products for pulmonary disease. Circassia could not beat the placebo in a Phase III trial for cat allergy last year, ...
This awesome article Can this British Biotech Overcome Failure buying drugs from AstraZeneca? appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)
Original Article: Can this British Biotech Overcome Failure buying drugs from AstraZeneca?NEXT ARTICLE
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...